J.R.S. Oryx Pharmaceuticals Pvt Ltd, a active private limited company, was established on 16 April 1993 in Karnal, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85110HR1993PTC031972. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.64 M.
It upholds a compliant status. Its leadership includes Surinder Pal (Director), Parveen Goyal (Director). Past directors included Nathi Ram Verma, Rattan Lal Sharma, Ravi Prakash. It holds ₹3.04 Cr open charges and ₹1.77 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 217& 218, Sector-3, Hsiidc, Industrial Area,, Karnal, Haryana, 132001.
U85110HR1993PTC031972
031972
16 April 1993
₹5.00 M
₹2.64 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into J.R.S. Oryx Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Pal | Director | 26 Apr 1993 | Current |
| Parveen Goyal | Director | 05 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 10 Feb 2025 | Past |
| Pramod Abcsdd | Director | 22 Oct 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
J.R.S. Oryx Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.75% decrease. The company also saw a slight improvement in profitability, with a 3.22% increase in profit. The company's net worth Soared by an impressive increase of 68.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, J.R.S. Oryx Pharmaceuticals had a promoter holding of 88.95% and a public holding of 11.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,350,000.00
₹17,650,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2018 | Others | ₹3.04 Cr | Open |
| 17 Sep 2020 | Others | ₹3.00 M | Satisfied |
| 09 Feb 2015 | L & T Finance Limited | ₹0.25 M | Satisfied |
| 18 Jun 2013 | Capital First Limited | ₹9.15 M | Satisfied |
| 26 May 2006 | Bank Of Punjab Limited | ₹2.25 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with J.R.S. Oryx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of J.R.S. Oryx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J.R.S. Oryx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 30.35 M registered on 20 Apr 2018 with Charge ID 100215901 was modified on 29 Apr 2025. was documented.
The activity Parveen Goyal was appointed as a Director was appointed as a Director on 05 Feb 2025 & has been associated with this company since 10 months 21 days . was completed.
J.R.S. Oryx Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity J.R.S. Oryx Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge registered on 17 Sep 2020 via Charge ID 100368825 with Others was fully satisfied on 16 Mar 2022. was completed.
Progress on A charge registered on 09 Feb 2015 via Charge ID 10573551 with L & T Finance Limited was fully satisfied on 02 Feb 2022. was documented.
The CIN of J.R.S. Oryx Pharmaceuticals Pvt Ltd is U85110HR1993PTC031972.
J.R.S. Oryx Pharmaceuticals Pvt Ltd is headquartered at 217& 218, Sector-3, Hsiidc, Industrial Area,, Karnal, Haryana, 132001.
J.R.S. Oryx Pharmaceuticals Pvt Ltd was incorporated on 16 April 1993.
The current directors of J.R.S. Oryx Pharmaceuticals Pvt Ltd are
The primary industry of J.R.S. Oryx Pharmaceuticals Pvt Ltd is Manufacturing.
J.R.S. Oryx Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of J.R.S. Oryx Pharmaceuticals Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹2.64 M.
The compliance status of J.R.S. Oryx Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX